Who We Are

Flexion Therapeutics is a biopharmaceutical company focused on advancing innovative, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis.

Read More

In North America 4.15% of adults have Knee OA

Unmet Need in Osteoarthritis

OA, also known as degenerative joint disease, affects more than 30 million Americans and accounts for more than $185 billion in annual expenditures.

See the Infographic

Our Product

A non-opioid, extended-release, intra-articular injection that employs our proprietary microsphere technology to treat OA knee pain.

Read More



Flexion continues to investigate the use of PLGA microspheres to deliver medicine at the site of disease over an extended period of time.

Read More

Our Pipeline

Beakers and flasks

Flexion’s strategy is to build a robust pipeline of locally administered therapies to address musculoskeletal conditions, with an initial focus on OA.

See the Pipeline

Join Our Team

Flexion Therapeutics prides itself on finding great talent, rewarding hard work and maintaining a culture that is unparalleled.

  • The Boston Globe Top Places to Work 2018
Learn More


March 12-16, 2019
AAOS 2019 Annual Meeting
Las Vegas, NV

January 4, 2019
8:30 AM EST
Flexion Therapeutics Corporate Update
Conference Call